Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 ...
Former Bristol Myers Squibb, Goldman Sachs, and Barclays executive brings deep expertise in corporate strategy, partnership development, public and private financial markets, and management as the ...